Michael W. Nall, Biocept's CEO & President and a director of the company, recently acquired 75,000 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on July 06, 2016. Nall now owns 114,634 shares of the company. Nall operates out of San Diego, CA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept director just picked up 5,667 shares - March 29, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017
Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017
Shareholder Director - March 23, 2017
CFO of Biocept was just granted 16,383 options - March 22, 2017